In fact, C5 proteolytic degradation promotes the release of the anaphylatoxin C5a that is an inflammatory mediator.27 Noteworthy, a peptide from C5a was also enhanced in CRC patient’s plasma (Figure 6C). This evidence concerns the gene C5 and colorectal carcinoma.